GB9805557D0 - A combination of therapeutic agents - Google Patents
A combination of therapeutic agentsInfo
- Publication number
- GB9805557D0 GB9805557D0 GBGB9805557.7A GB9805557A GB9805557D0 GB 9805557 D0 GB9805557 D0 GB 9805557D0 GB 9805557 A GB9805557 A GB 9805557A GB 9805557 D0 GB9805557 D0 GB 9805557D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- combination
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9805557.7A GB9805557D0 (en) | 1998-03-16 | 1998-03-16 | A combination of therapeutic agents |
US09/622,952 US6455552B1 (en) | 1998-03-16 | 1999-03-16 | Combination of a GABAA α5 inverse agonist and a muscarinic agonist |
AU28478/99A AU2847899A (en) | 1998-03-16 | 1999-03-16 | Combination of a gaba-a alpha 5 inverse agonist and a muscarinic agonist |
PCT/GB1999/000801 WO1999047171A1 (en) | 1998-03-16 | 1999-03-16 | Combination of a gaba-a alpha 5 inverse agonist and a muscarinic agonist |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9805557.7A GB9805557D0 (en) | 1998-03-16 | 1998-03-16 | A combination of therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9805557D0 true GB9805557D0 (en) | 1998-05-13 |
Family
ID=10828628
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9805557.7A Ceased GB9805557D0 (en) | 1998-03-16 | 1998-03-16 | A combination of therapeutic agents |
Country Status (4)
Country | Link |
---|---|
US (1) | US6455552B1 (en) |
AU (1) | AU2847899A (en) |
GB (1) | GB9805557D0 (en) |
WO (1) | WO1999047171A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6271241B1 (en) | 1999-04-02 | 2001-08-07 | Neurogen Corporation | Cycloalkyl and aryl fused aminoalkyl-imidazole derivatives: modulators and GLP-1 receptors |
US6281237B1 (en) | 1999-04-02 | 2001-08-28 | Neurogen Corporation | N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives |
US6380210B1 (en) | 1999-04-02 | 2002-04-30 | Neurogen Corporation | Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
US6627624B1 (en) | 1999-04-02 | 2003-09-30 | Neurogen Corporation | Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
US6723332B2 (en) | 2000-05-26 | 2004-04-20 | Neurogen Corporation | Oxomidazopyridine-carboxamides |
US6828329B2 (en) | 2000-06-26 | 2004-12-07 | Neurogen Corporation | Aryl fused substituted 4-oxy-pyridines |
IL159811A0 (en) | 2001-07-13 | 2004-06-20 | Neurogen Corp | Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
CA2573673A1 (en) * | 2004-07-16 | 2006-01-26 | Proteosys Ag | Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents |
WO2019180224A1 (en) * | 2018-03-22 | 2019-09-26 | Nsc Therapeutics Gmbh | Compounds and methods for use in the treatment of microglia-mediated disorders |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4647580A (en) | 1985-07-18 | 1987-03-03 | Syntex (U.S.A.) Inc. | Treatment of Alzheimer's disease |
DK198590D0 (en) | 1990-08-21 | 1990-08-21 | Novo Nordisk As | HETEROCYCLIC COMPOUNDS, THEIR PREPARATION AND USE |
GB9503601D0 (en) | 1995-02-23 | 1995-04-12 | Merck Sharp & Dohme | Method of treatment and method of manufacture of medicament |
AU724076B2 (en) | 1996-07-25 | 2000-09-14 | Merck Sharp & Dohme Limited | Substituted triazolo pyridazine derivatives as inverse agonists of the GABAAalpha5 receptor subtype |
AU732455C (en) | 1997-05-08 | 2002-09-05 | Merck Sharp & Dohme Limited | Substituted 1,2,4-triazolo{3,4-a}phthalazine derivatives as gaba alpha 5 ligands |
-
1998
- 1998-03-16 GB GBGB9805557.7A patent/GB9805557D0/en not_active Ceased
-
1999
- 1999-03-16 AU AU28478/99A patent/AU2847899A/en not_active Abandoned
- 1999-03-16 WO PCT/GB1999/000801 patent/WO1999047171A1/en active Application Filing
- 1999-03-16 US US09/622,952 patent/US6455552B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US6455552B1 (en) | 2002-09-24 |
WO1999047171A1 (en) | 1999-09-23 |
AU2847899A (en) | 1999-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9805561D0 (en) | A combination of therapeutic agents | |
GB9820113D0 (en) | Therapeutic agents | |
GB9708484D0 (en) | Therapeutic agents | |
GB9816263D0 (en) | Therapeutic agents | |
GB9708945D0 (en) | Therapeutic agents | |
GB9806102D0 (en) | Therapeutic agents | |
GB9704948D0 (en) | Therapeutic agents | |
GB9702524D0 (en) | Therapeutic agents | |
GB9711753D0 (en) | Therapeutic agents | |
GB9713707D0 (en) | Therapeutic agents | |
GB9808663D0 (en) | Therapeutic agents | |
GB9711114D0 (en) | Therapeutic agents | |
GB9801234D0 (en) | Therapeutic agents | |
GB9813576D0 (en) | Therapeutic agents | |
GB9813006D0 (en) | Therapeutic agents | |
GB9801210D0 (en) | Therapeutic agents | |
AP9901436A0 (en) | Therapeutic agents | |
GB9801397D0 (en) | Therapeutic agents | |
GB9805557D0 (en) | A combination of therapeutic agents | |
GB9801202D0 (en) | Therapeutic agents | |
GB9700555D0 (en) | Therapeutic agents | |
GB9810092D0 (en) | Therapeutic agents | |
GB9819484D0 (en) | Therapeutic agents | |
GB9811879D0 (en) | Therapeutic agents | |
GB9805716D0 (en) | Therapeutic agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |